Extra shareholders’ meeting at Diamyd Medical AB approves a new share issue of 220 MSEK
The extra shareholders’ meeting at Diamyd Medical AB (publ) held today decided, in accordance with the proposal put forward by the Board of Directors, to implement a new share issue of just under 220 MSEK with preferential rights for existing shareholders. The rights issue is 100% underwritten through subscription undertakings and underwriting guarantees.The additional capital is required to cover with margin the costs that the Company anticipates incurring up to spring 2011, when data from the current Phase III program is expected to be available, and to strengthen the Company’s bargaining